<p>Eurofins Scientific SE has announced a series of internal dealings involving the acquisition of shares. Analytical Bioventures S.C.A., a company controlled by Eurofins Scientific SE CEO Dr. Gilles Martin, acquired 1,000 shares of Eurofins Scientific SE at a price of EUR 68.0527 per share on January 6, 2026, 1,000 shares at EUR 68.8441 per share and another 1,000 shares at EUR 68.8344 per share on January 8, 2026, and 1,000 shares at EUR 69.5932 per share on January 9, 2026. All transactions took place on the Euronext Paris exchange (XPAR). Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eurofins Scientific SE published the original content used to generate this news brief via Business Wire (Ref. ID: 20260112155141) on January 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

Eurofins Scientific SE Reports Director-Linked Acquisition of Shares